Unity Biotechnology, Inc. (0YC0.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 16.2M |
| Enterprise Value | 32.16M |
| P/E Ratio | -0.21 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 2.59 |
| Price/Book Ratio | -16.47 |
| Enterprise/Revenue | 13.59 |
| Enterprise/EBITDA | -1.21 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
| Profit Margin | -11.85 |
| Operating Margin | -10.72 |
| Return On Assets | -0.52 |
| Return On Equity | -5.01 |
| Revenue | 0 |
| Revenue/Share | 0.08 |
| Gross Profit | -867,000 |
| EBITDA | -25.12M |
| Net Income | -25.99M |
| Diluted EPS | -1.54 |
| Total Cash | 16.93M |
| Total Cash/Share | 1 |
| Total Debt | 22.58M |
| Total Debt/Equity | -110.28 |
| Current Ratio | 1.95 |
| Book Value Per Share | -0.01 |
| 52-Week Change | -95.45 |
| 52-Week High | 3.79 |
| 52-Week Low | 0.06 |
| Moving Average 50 Days | 1.83 |
| Moving Average 200 Days | 2.31 |
| Average Volume | 551 |
| Shares Outstanding | 17.21M |
| % Held by Institutions | 0.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 30, 2023 |